Targeting TAK1 to overcome cisplatin resistance in lung adenocarcinoma by rewiring the NF-κB and p53 signaling

Authors:

Abstract
No abstract available
Funding Information
  • Hainan Provincial Department of Science and Technology
  • National Natural Science Foundation of China